International Clinical Trial: A Food Effect Open-Label, Randomized Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OV4071 in Healthy Male and Female Participants

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000481370) titled 'A Food Effect Open-Label, Randomized Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OV4071 in Healthy Male and Female Participants' on April 17.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Ovid Therapeutics Australia Pty Ltd

Condition: Parkinson's Disease Parkinson's Disease Neurological - Parkinson's disease

Intervention: The study will be a Phase 1, single-centre, randomized, open-label food effect inpatient study of the safety and tolerability of a single dose of oral OV4071 in healthy male ...